New Paragon spinout lands $275M financing — and reverse merger

The third spinout from Paragon Therapeutics launched on Wednesday with a new private financing — and, in an unusual move, a plan to go public within a few months.

Source: bizjournals.com Health Care:Biotechnology headlines - April 3, 2024 Category: Biotechnology Authors: Hannah Green Source Type: news